Identification of important interactions between subchondral bone ...

19 Brandt K.D. Animal models of osteoarthritis.
Biorheology. 2002;39(1-2):221-235.
20 Helminen H.J., Saamanen A.M., Salminen H., and
Hyttinen M.M. Transgenic mouse models for studying the
role of cartilage macromolecules in osteoarthritis.
Rheumatology (Oxford). 2002;41(8):848-856.
21 Glasson S.S. In vivo osteoarthritis target validation
utilizing genetically-modified mice. Curr Drug Targets.
2007;8(2):367-376.
22 Manicourt D.H., Altman R.D., Williams J.M., Devogelaer
J.P., Druetz-Van E.A., Lenz M.E., Pietryla D. et al.
Treatment with calcitonin suppresses the responses of
bone, cartilage, and synovium in the early stages of canine
experimental osteoarthritis and significantly reduces the
severity of the cartilage lesions. Arthritis Rheum.
1999;42(6):1159-1167.
23 Behets C., Williams J.M., Chappard D., Devogelaer J.P.,
and Manicourt D.H. Effects of calcitonin on subchondral
trabecular bone changes and on osteoarthritic cartilage
lesions after acute anterior cruciate ligament deficiency. J
Bone Miner Res. 2004;19(11):1821-1826.
24 Bendele A.M., White S.L., and Hulman J.F. Osteoarthrosis
in guinea pigs: histopathologic and scanning electron
microscopic features. Lab Anim Sci. 1989;39(2):115-121.
25 Jimenez P.A., Glasson S.S., Trubetskoy O.V., and Haimes
H.B. Spontaneous osteoarthritis in Dunkin Hartley guinea
pigs: histologic, radiologic, and biochemical changes. Lab
Anim Sci. 1997;47(6):598-601.
26 Sondergaard B.C. The Pharmacological Role of Calcitonin
in Osteoarthritis. PhD thesis. 2010;41-41.
CHAPTER 3: Overview of OA models
49
27 Goldring S.R. and Goldring M.B. The role of cytokines in
cartilage matrix degeneration in osteoarthritis. Clin Orthop
Relat Res. 2004;(427 Suppl):S27-S36.
28 Goldring M.B. Update on the biology of the chondrocyte
and new approaches to treating cartilage diseases. Best
Pract Res Clin Rheumatol. 2006;20(5):1003-1025.
29 Hui W., Rowan A.D., Richards C.D., and Cawston T.E.
Oncostatin M in combination with tumor necrosis factor
alpha induces cartilage damage and matrix
metalloproteinase expression in vitro and in vivo. Arthritis
Rheum. 2003;48(12):3404-3418.
30 Kronenberg H.M. Developmental regulation of the
growth plate. Nature. 2003;423(6937):332-336.
31 van Osch G.J., Mandl E.W., Marijnissen W.J., van d., V,
Verwoerd-Verhoef H.L., and Verhaar J.A. Growth factors
in cartilage tissue engineering. Biorheology. 2002;39(1-
2):215-220.
32 Tyler J.A. Insulin-like growth factor 1 can decrease
degradation and promote synthesis of proteoglycan in
cartilage exposed to cytokines. Biochem J.
1989;260(2):543-548.
33 Verschure P.J., Van Noorden C.J., Van M.J., and Van den
Berg W.B. Articular cartilage destruction in experimental
inflammatory arthritis: insulin-like growth factor-1
regulation of proteoglycan metabolism in chondrocytes.
Histochem J. 1996;28(12):835-857.
34 Wahl A.F. and Wallace P.M. Oncostatin M in the antiinflammatory
response. Ann Rheum Dis. 2001;60 Suppl
3:iii75-iii80.